I want to keep you guys in the loop on something happening in the research peptide world. This is NOT a panic post. ❤️ Nobody needs to freak out, stockpile everything, or assume peptides are disappearing tomorrow. But, there has been increased FDA enforcement involving companies selling research peptides, and some recent warning letters give us a much clearer picture of what the FDA is paying attention to. One of the biggest takeaways is this: Simply labeling something “FOR RESEARCH USE ONLY” does not automatically protect a company if the rest of its website, advertising or communication makes it sound like the product is being sold for people to use. That means our WORDS matter. GLP-1 LAB has always been a place to learn, research, ask questions and share experiences, and I want us to be especially thoughtful about how we talk about research peptides going forward. For example, instead of: ❌ “Take this peptide for weight loss.” Try: ✅ “This peptide is being researched for its effects on body weight and metabolism.” Instead of: ❌ “You should take 2 mg per week.” Try: ✅ “In this study, researchers evaluated doses of ___.” Instead of: ❌ “This will heal your injury.” Try: ✅ “Researchers are studying this peptide for its potential role in tissue repair.” Instead of: ❌ “Buy this peptide and I'll show you how to use it.” Try: ✅ “Here are resources where you can learn more about the research.” And when sharing your own experience, make that clear: ✅ “In my personal experience…” ✅ “This is what I noticed…” ✅ “Here is the research I found…” ✅ “Here's a study worth reading…” Personal experience is not the same thing as making a medical claim or telling another person what they should do. ------------------------------------------------------------ ❤️ What does this mean for GLP-1 LAB? We keep learning & researching. I am actively following FDA announcements, warning letters and changes affecting research peptides. I'm also taking a very close look at how we communicate in this Skool group so we can continue to be a responsible research community.